Yasin Tiryaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasin Tiryaki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Burak Sarıkaya
Department of Infectious Diseases and Clinical Microbiology, Sultan 2. Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye
1 shared publication - Duygu Kirkik
University of Health Sciences
1 shared publication - İrEm Demiralp Yatar
University of Health Sciences, Sultan 2, Turkey
1 shared publication - Mehtap Toprak
Department of Pathology, Sultan 2. Abdulhamid Han Training and Research Hospital, University of Health Sciences, 34668 Istanbul, Turkey
1 shared publication - Rıza Aytaç Çetinkaya
Reyap Health Group, Turkey
1 shared publication - Soner Yılmaz
Gülhane Training and Research Hospital, University of Health Sciences Ankara Turkey
1 shared publication
Latest Publications
- Open Access
Serological Screening for HIV, Hepatitis B, Hepatitis C, and Syphilis in Patients with Genital Molluscum Contagiosum: A Retrospective Cross-Sectional Study
(1) Background: The available literature on sexually transmitted infections in patients with genital molluscum contagiosum is limited. In this study, we aimed to evaluate the serological test results and screening rate for sexually transmitted infections, including human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis, among patients with genital molluscum contagiosum. (2) Methods: In this retrospective cross-sectional study, we reviewed the medical records of patients aged ≥18 years diagnosed with genital molluscum contagiosum at our dermatology outpatient clinic between October 2016 and December 2025. Age, sex, and serological test results for anti-human immunodeficiency virus, hepatitis B surface antigen, anti-hepatitis C virus, and Venereal Disease Research Laboratory/Rapid Plasma Reagin were recorded. (3) Results: Serological screening was performed in 202 of 528 patients (38.3%), and 11 (5.45%) had positive test results for at least one sexually transmitted infection. (4) Conclusions: Our findings support routine screening for sexually transmitted infections in patients with genital molluscum contagiosum, given that a substantial proportion of these patients do not undergo serological screening.
Open AccessSerological Screening for HIV, Hepatitis B, Hepatitis C, and Syphilis in Patients with Genital Molluscum Contagiosum: A Retrospective Cross-Sectional Study
(1) Background: The available literature on sexually transmitted infections in patients with genital molluscum contagiosum is limited. In this study, we aimed to evaluate the serological test results and screening rate for sexually transmitted infections, including human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis, among patients with genital molluscum contagiosum. (2) Methods: In this retrospective cross-sectional study, we reviewed the medical records of patients aged ≥18 years diagnosed with genital molluscum contagiosum at our dermatology outpatient clinic between October 2016 and December 2025. Age, sex, and serological test results for anti-human immunodeficiency virus, hepatitis B surface antigen, anti-hepatitis C virus, and Venereal Disease Research Laboratory/Rapid Plasma Reagin were recorded. (3) Results: Serological screening was performed in 202 of 528 patients (38.3%), and 11 (5.45%) had positive test results for at least one sexually transmitted infection. (4) Conclusions: Our findings support routine screening for sexually transmitted infections in patients with genital molluscum contagiosum, given that a substantial proportion of these patients do not undergo serological screening.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (8) , e20240370
The usefulness of anti-HCV signal to cut-off ratio in predicting hepatitis C viremia and the effect of genotype differences on signal to cut-off ratio
In the hepatitis C virus (HCV) diagnostic algorithm, an anti-HCV screening test is recommended first. In countries with low HCV prevalence, anti-HCV testing can often give false-positive results. This may lead to unnecessary retesting, increased costs, and psychological stress for patients.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (8) , e20240370
Open AccessThe usefulness of anti-HCV signal to cut-off ratio in predicting hepatitis C viremia and the effect of genotype differences on signal to cut-off ratio
In the hepatitis C virus (HCV) diagnostic algorithm, an anti-HCV screening test is recommended first. In countries with low HCV prevalence, anti-HCV testing can often give false-positive results. This may lead to unnecessary retesting, increased costs, and psychological stress for patients.